Jul. 17 at 1:04 PM
$PCSA PCSA is a classic catalyst-rich microcap:
Clinical milestone ahead (NGC‑Cap)
Big licensing deal in progress (PCS12852)
Insider buying signals strong confidence
Funding secured
If you're playing for a biotech rally into H2 2025, this is one of the cleanest setups out there.